NO881719L - Syntetisk hiv-2-antigen. - Google Patents

Syntetisk hiv-2-antigen.

Info

Publication number
NO881719L
NO881719L NO881719A NO881719A NO881719L NO 881719 L NO881719 L NO 881719L NO 881719 A NO881719 A NO 881719A NO 881719 A NO881719 A NO 881719A NO 881719 L NO881719 L NO 881719L
Authority
NO
Norway
Prior art keywords
hiv
antigen
synthetic hiv
elicit
glycoprotein
Prior art date
Application number
NO881719A
Other languages
English (en)
Other versions
NO881719D0 (no
Inventor
Anders Vahlne
Bo Svennerholm
Lars Rymo
Stig Jeansson
Peter Horal
Original Assignee
Syntello Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntello Ab filed Critical Syntello Ab
Publication of NO881719D0 publication Critical patent/NO881719D0/no
Publication of NO881719L publication Critical patent/NO881719L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/221—Retrovirus related, or human immunodeficiency virus related, or simian immunodeficiency virus related

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO881719A 1987-05-18 1988-04-21 Syntetisk hiv-2-antigen. NO881719L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/051,727 US4812556A (en) 1987-05-18 1987-05-18 Synthetic peptide antigen for the detection of HIV-2 infection

Publications (2)

Publication Number Publication Date
NO881719D0 NO881719D0 (no) 1988-04-21
NO881719L true NO881719L (no) 1988-11-21

Family

ID=21973023

Family Applications (1)

Application Number Title Priority Date Filing Date
NO881719A NO881719L (no) 1987-05-18 1988-04-21 Syntetisk hiv-2-antigen.

Country Status (11)

Country Link
US (1) US4812556A (no)
EP (1) EP0292454B1 (no)
AT (1) ATE83247T1 (no)
AU (1) AU606951B2 (no)
DE (1) DE3876496T2 (no)
DK (1) DK268588A (no)
ES (1) ES2011334A6 (no)
FI (1) FI882173L (no)
NO (1) NO881719L (no)
NZ (1) NZ224581A (no)
ZA (1) ZA883431B (no)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8701628D0 (sv) * 1987-04-16 1987-04-16 Erling Norrby Medel for analys mm
US5019387A (en) * 1987-09-08 1991-05-28 Duke University Production of antibodies to HIV
SE8704185L (sv) * 1987-10-28 1989-04-29 Ferring Ab Nya peptider, artificiella antigener och immunoanalystestsatser
EP0316695B1 (de) * 1987-11-16 1993-03-31 F. Hoffmann-La Roche Ag Rekombinante HIV-2 Polypeptide
US5780038A (en) * 1987-11-16 1998-07-14 Roche Diagnostic Systems, Inc. HIV-2 envelope polypeptides
US5241047A (en) * 1988-12-08 1993-08-31 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US6210874B1 (en) 1988-01-27 2001-04-03 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US6214537B1 (en) * 1988-01-27 2001-04-10 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
WO1989009785A1 (en) * 1988-04-07 1989-10-19 The Trustees Of The University Of Alabama Peptides inhibitors of hiv induced cell fusions and syncytia formation
EP0362927A3 (en) * 1988-10-06 1990-11-14 Akzo N.V. Synthetic polypeptides immunochemically reactive with hiv antibodies
EP0449955B1 (en) * 1988-12-20 1996-03-06 Clarity Technologies Incorporated Synthetic hiv-like peptides, their compositions and uses
US5260189A (en) * 1988-12-20 1993-11-09 Immunodiagnostics, Inc. Synthetic HIV-like peptides their compositions and uses
CA2017021A1 (en) * 1989-05-22 1990-11-22 Johannes Jacobus Schalken Diagnostic test for detecting antibodies directed against antigens of one or more related viruses
JPH0338599A (ja) * 1989-07-05 1991-02-19 Calpis Food Ind Co Ltd:The 抗ｈｉｖペプチド及び抗ｈｉｖ修飾ペプチド
US6083504A (en) * 1989-08-24 2000-07-04 Bioclonetics Incorporated Human monoclonal antibodies directed against the transmembrane glycoprotein (GP41) of human immunodeficiency virus-1 (HIV-1)
US5459060A (en) * 1989-08-24 1995-10-17 Bioclonetics Incorporated Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1)
US6008044A (en) * 1989-08-24 1999-12-28 Bioclonetics Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1) and detection of antibodies against epitope (GCSGKLIC)
EP0438332B1 (fr) * 1990-01-16 1998-04-08 Orgenics Ltd. Peptides dérivant de la glycoprotéine d'enveloppe de virus HIV, leurs applications à la détection d'une infection due à ces virus et à la vaccination contre le SIDA
FR2657016B1 (fr) * 1990-01-16 1995-08-25 Clonatec Sa Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-2, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
JPH06503843A (ja) * 1991-11-04 1994-04-28 デイド、インターナショナル、インコーポレイテッド Ｈｉｖ−２ウイルスの一部分に対応する合成ペプチドおよび改良されたイムノアッセイにおけるその使用方法
US6274552B1 (en) 1993-03-18 2001-08-14 Cytimmune Sciences, Inc. Composition and method for delivery of biologically-active factors
US5420244A (en) * 1993-08-06 1995-05-30 The United States Of America As Represented By The Department Of Health And Human Services Methods and compositions for diagnosing HTLV-I associated myelopathy and adult T-cell leukemia
US20010055581A1 (en) * 1994-03-18 2001-12-27 Lawrence Tamarkin Composition and method for delivery of biologically-active factors
US7229841B2 (en) * 2001-04-30 2007-06-12 Cytimmune Sciences, Inc. Colloidal metal compositions and methods
US6407218B1 (en) 1997-11-10 2002-06-18 Cytimmune Sciences, Inc. Method and compositions for enhancing immune response and for the production of in vitro mabs
US6537631B1 (en) * 1999-04-30 2003-03-25 Kimberly-Clark Worldwide, Inc. Roll of wet wipes
AU2002339876A1 (en) * 2001-09-04 2003-03-18 Wisconsin Alumni Research Foundation Liquid crystal switching mechanism
EP1438433A4 (en) * 2001-10-04 2005-12-21 Wisconsin Alumni Res Found EVIDENCE OF HYBRIDIZATION OF DNA ON SURFACES
US7807348B2 (en) * 2002-03-20 2010-10-05 Wisconsin Alumni Research Foundation Optical imaging of nanostructured substrates
US7125592B2 (en) * 2002-04-10 2006-10-24 Wisconsin Alumni Research Foundation Detecting interactions at biomimetic interfaces with liquid crystals
WO2004044583A1 (en) * 2002-11-08 2004-05-27 Wisconsin Alumni Research Foundation Surfaces with gradients in surface topography
WO2005010160A2 (en) * 2003-07-17 2005-02-03 Wisconsin Alumni Research Foundation Liquid crystals with reduced toxicity and applications thereof
AU2004311630A1 (en) * 2003-12-02 2005-07-21 Cytimmune Sciences, Inc. Methods and compositions for the production of monoclonal antibodies
AU2005209318B2 (en) * 2004-01-28 2010-02-11 Cytimmune Sciences, Inc. Functionalized colloidal metal compositions and methods
WO2007111681A2 (en) * 2005-10-31 2007-10-04 Wisconsin Alumni Research Foundation Device and methods for liquid crystal-based bioagent detection
US20110014118A1 (en) * 2007-09-21 2011-01-20 Lawrence Tamarkin Nanotherapeutic colloidal metal compositions and methods
JP2011520769A (ja) * 2007-09-21 2011-07-21 サイトイミューン サイエンシズ インコーポレイテッド ナノ治療コロイド金属組成物および方法
CA2706700A1 (en) * 2007-11-08 2009-05-14 Cytimmune Sciences, Inc. Compositions and methods for generating antibodies
US20130306629A1 (en) * 2012-05-21 2013-11-21 Hanna Asfaw Unity Cup

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3760912D1 (en) * 1986-01-22 1989-12-07 Pasteur Institut Retrovirus of the type hiv-2 capable of inducing aids, and the antigenic and nucleic acid components thereof

Also Published As

Publication number Publication date
ES2011334A6 (es) 1990-01-01
EP0292454A2 (en) 1988-11-23
NZ224581A (en) 1990-09-26
DE3876496T2 (de) 1993-05-13
DK268588A (da) 1988-11-19
FI882173A7 (fi) 1988-11-19
ZA883431B (en) 1988-11-17
DE3876496D1 (de) 1993-01-21
FI882173L (fi) 1988-11-19
AU606951B2 (en) 1991-02-21
US4812556A (en) 1989-03-14
EP0292454B1 (en) 1992-12-09
AU1645688A (en) 1988-11-24
ATE83247T1 (de) 1992-12-15
FI882173A0 (fi) 1988-05-10
EP0292454A3 (en) 1989-10-04
DK268588D0 (da) 1988-05-17
NO881719D0 (no) 1988-04-21

Similar Documents

Publication Publication Date Title
NO881719D0 (no) Syntetisk hiv-2-antigen.
FI904345A0 (fi) Syntetisk peptidantigen foer detektering av htlv-1 infektion.
EP0284587A3 (en) Synthetic peptide antigens for the detection of hiv-1 infection
DE69334148D1 (de) HIV-Peptide
DE69013950D1 (de) Monoklonaler Antikörper zur Unterscheidung HIV-2-seropositiver von HIV-1-seropositiven Individuen.
NO173958C (no) Fremgangsmaate for paavisning av tilstedevaerelse av antistoff mot HIV-virus
ATE7855T1 (de) Herstellung von virusantigenen.
EP0449955A4 (en) Synthetic hiv-like peptides, their compositions and uses
SE8902148D0 (sv) Syntetiska peptid antigen foer detektion av htlv-1 infektion
DE3672624D1 (de) Verfahren zum nachweis von htlv-iii neutralisierenden antikoerpern in sera.
AU608413B2 (en) Mouse monoclonal antibody (5-21-3) to human immunodeficiency virus gp41 protein
GR3033885T3 (en) Synthetic antigens for the detection of aids-related disease caused by LAV-2.
DE69026875D1 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
SE8701294L (sv) Hiv-peptid